SCHEMBL3344966

SCHEMBL3344966

CCc1cnc(N2CCC(Oc3cccc(-c4cccc(S(C)(=O)=O)c4)c3)CC2)nc1

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3342654 0.93 GPR119 (0.61) GPR119
SCHEMBL3342698 0.93 GPR119 (0.68) GPR119
SCHEMBL3342636 0.79 GPR119 (0.60) GPR119
SCHEMBL1937919 0.79 GPR119 (0.48) GPR119
SCHEMBL2333925 0.78 GPR119 (1.00) GPR119
SCHEMBL523600 0.76 JAK2 (0.46) GPR119
SCHEMBL2333285 0.76 GPR119 (0.88) GPR119
SCHEMBL1549932 0.76 GPR119 (0.76) GPR119
SCHEMBL8532761 0.75 GPR119 (0.72) GPR119
SCHEMBL8512052 0.75 GPR119 (0.72) GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010048149-A2 HETEROCYCLIC MODULATORS OF GPR119 FOR TREATMENT OF DISEASE KALYPSYS, INC. (US) 2010-04-29 WO disclosed